FDA Releases New Tools to Speed COVID-19 Test Development

The US agency on 29 May gave two additional tools to COVID-19 test developers: an emergency use authorization template for tests using at-home sample collection kits, and a reference panel for the disease.

FDA entrance sign 2016

More from Regulation

More from Policy & Regulation